Therapeutic protein aggregation: mechanisms, design, and control.
Therapeutic protein aggregation: mechanisms, design, and control.
复制标题
DOI:
10.1016/j.tibtech.2014.05.005
复制
发表时间:
2014-07
影响因子:
17.3
通讯作者:
Roberts, Christopher J.
中科院分区:
文献类型:
--
作者:
Roberts, Christopher J.
While it is well known that proteins are only marginally stable in their folded states, it is often less well appreciated that most proteins are inherently aggregation-prone in their unfolded or partially unfolded states, and the resulting aggregates can be extremely stable and long-lived. For therapeutic proteins, aggregates are a significant risk factor for deleterious immune responses in patients, and can form via a variety of mechanisms. Controlling aggregation using a mechanistic approach may allow improved design of therapeutic protein stability, as a complement to existing design strategies that target desired protein structures and function. Recent results highlight the importance of balancing protein environment with the inherent aggregation propensities of polypeptide chains.
登录
查看更多内容
影响因子:
3.8
作者:
Arosio, Paolo;Jaquet, Baptiste;Morbidelli, Massimo
通讯作者:
Morbidelli, Massimo
影响因子:
5.6
作者:
Famm, Kristoffer;Hansen, Lars;Winter, Greg
通讯作者:
Winter, Greg
影响因子:
4.8
作者:
Flaugh, Shannon L.;Mills, Ishara A.;King, Jonathan
通讯作者:
King, Jonathan
DOI:
10.1073/pnas.1202866109
发表时间:
2012-07-03
影响因子:
11.1
作者:
Dudgeon, Kip;Rouet, Romain;Christ, Daniel
通讯作者:
Christ, Daniel
影响因子:
3.8
作者:
Bee, Jared S.;Davis, Michele;Freund, Erwin;Carpenter, John F.;Randolph, Theodore W.
通讯作者:
Randolph, Theodore W.